Davis Polk advised the sales agent on the offering.ImmunityBio, Inc. executed an at-the-market offering of its common stock for up to an aggregate amount of $500 million. Based…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
